These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8061581)

  • 1. Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine.
    Gerner EW; Garewal HS; Emerson SS; Sampliner RE
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):325-30. PubMed ID: 8061581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus.
    Garewal HS; Gerner EW; Sampliner RE; Roe D
    Cancer Res; 1988 Jun; 48(11):3288-91. PubMed ID: 3130189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive studies in Barrett's esophagus: a model premalignant lesion for esophageal adenocarcinoma.
    Garewal HS; Sampliner RE; Fennerty MB
    J Natl Cancer Inst Monogr; 1992; (13):51-4. PubMed ID: 1389696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethylornithine.
    Boyle JO; Meyskens FL; Garewal HS; Gerner EW
    Cancer Epidemiol Biomarkers Prev; 1992; 1(2):131-5. PubMed ID: 1306095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of difluoromethylornithine for the chemoprevention of Barrett's esophagus and mucosal dysplasia.
    Sinicrope FA; Broaddus R; Joshi N; Gerner E; Half E; Kirsch I; Lewin J; Morlan B; Hong WK
    Cancer Prev Res (Phila); 2011 Jun; 4(6):829-39. PubMed ID: 21636549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
    Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
    Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
    Meyskens FL; Gerner EW
    Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sources of variability in estimating ornithine decarboxylase activity and polyamine contents in human colorectal mucosa.
    Hixson LJ; Emerson SS; Shassetz LR; Gerner EW
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):317-23. PubMed ID: 8061580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine.
    Pfaller MA; Riley J; Gerarden T
    J Med Vet Mycol; 1988 Apr; 26(2):119-26. PubMed ID: 3138402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and a transplantable fibrosarcoma.
    Grossie VB; Ota DM; Ajani JA; Nishioka K
    Cancer Res; 1987 Apr; 47(7):1836-40. PubMed ID: 3102050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy.
    Amano Y; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Ishimura N; Furuta K; Ishihara S; Adachi K; Maruyama R; Kinoshita Y
    J Gastroenterol Hepatol; 2007 Jun; 22(6):901-7. PubMed ID: 17565646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
    Jankowski J; Hopwood D; Pringle R; Wormsley KG
    Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
    Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
    O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
    Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.
    Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
    Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
    J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatments with alpha-difluoromethylornithine and hyperthermia on the growth and polyamine metabolism of Harding-Passey murine melanoma.
    Lopez Ballester JA; Peñafiel R; Cremades A; Valcarcel MM; Solano F; Lozano JA
    Anticancer Res; 1991; 11(2):691-6. PubMed ID: 1905904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.